View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 20, 2019

Medtronic introduces Telescope guide extension catheter

Medtronic has globally launched its new guide extension catheter, Telescope, to deliver interventional devices such as coronary stents and balloons during angioplasty procedures.

Medtronic has globally launched its new guide extension catheter, Telescope, to deliver interventional devices such as coronary stents and balloons during angioplasty procedures.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The device has been designed to offer additional backup support and access to distal lesions.

Medtronic developed Telescope in alliance with interventional cardiologists to enable improved and smooth delivery of interventional devices in complex cases.

The guide extension catheter features a solid, round pushwire in combination with a coil-reinforced hydrophilic-coated distal segment to enable access to challenging lesions with better pushability and deliverability.

In addition, the device is integrated with a flexible TruFlexsoft polymer tip designed for bending and deflection during use.

It also includes SmoothPass technology for smooth channelling of stents, balloons and other interventional devices into place, after the catheter is in position near the target lesion.

Medtronic Coronary and Renal Denervation business vice-president and general manager Dave Moeller said: “Before bringing this important technology to market, we collaborated with more than 700 interventional cardiologists to ensure Telescope was addressing unmet needs in complex PCI.

“We will continue to make investments in cutting edge interventional technologies, clinical evidence expansion, and robust physician training programmes, which we believe will make a meaningful difference for physicians and their patients.”

“Before bringing this important technology to market, we collaborated with more than 700 interventional cardiologists to ensure Telescope was addressing unmet needs.”

The company’s coronary portfolio additionally includes Resolute Onyx drug-eluting stent (DES), Euphora pre- and post-dilatation balloon catheters range and a suite of catheters including the DxTerity TRA Diagnostic Catheter and Launcher Guide Catheter.

Earlier this month, Medtronic introduced Solitaire X, a revascularisation device intended to treat patients with acute ischemic stroke, in the US.

The device is meant for mechanical removal of blood clots from blocked vessels in the brain. Solitaire X is the company’s fourth generation device.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network